Jacobs Levy Equity Management, Inc Lexicon Pharmaceuticals, Inc. Transaction History

Jacobs Levy Equity Management, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$1.44 - $2.1 $315,807 - $460,553	-219,311 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$1.75 - $2.3 $326,947 - $429,702	-186,827 Reduced 46.0%	219,311 $438,000
Q1 2020 May 15, 2020	BUY	$1.8 - $4.28 $66,411 - $157,910	36,895 Added 9.99%	406,138 $792,000
Q4 2019 Feb 14, 2020	SELL	$3.16 - $5.15 $679,592 - $1.11 Million	-215,061 Reduced 36.81%	369,243 $1.53 Million
Q3 2019 Nov 14, 2019	BUY	$1.2 - $6.66 $583,994 - $3.24 Million	486,662 Added 498.41%	584,304 $1.76 Million
Q2 2019 Aug 13, 2019	SELL	$5.35 - $7.11 $375,158 - $498,574	-70,123 Reduced 41.8%	97,642 $614,000
Q1 2019 May 14, 2019	SELL	$4.36 - $7.94 $345,857 - $629,840	-79,325 Reduced 32.1%	167,765 $933,000
Q4 2018 Feb 14, 2019	BUY	$6.15 - $10.51 $453,624 - $775,217	73,760 Added 42.55%	247,090 $1.64 Million
Q3 2018 Nov 14, 2018	BUY	$10.32 - $13.06 $22,941 - $29,032	2,223 Added 1.3%	173,330 $1.85 Million
Q2 2018 Aug 14, 2018	BUY	$7.8 - $13.69 $635,411 - $1.12 Million	81,463 Added 90.87%	171,107 $2.05 Million
Q1 2018 May 15, 2018	SELL	$7.86 - $11.39 $428,330 - $620,698	-54,495 Reduced 37.81%	89,644 $768,000
Q4 2017 Feb 13, 2018	BUY	$8.77 - $12.28 $1.26 Million - $1.77 Million	144,139	144,139 $1.42 Million

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.